Use of gas reduction energy at a gas distribution station
Liquid and Gaseous Energy Resources · 2022
DOI: 10.21595/lger.2022.22421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liquid and Gaseous Energy Resources, 2022. Verfasst von Aigul Karimova und 1 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The issue of utilization of excess energy of throttled natural gas is still relevant today. To solve it, various devices are used, based on such principles as on the Ranque-Hilsch vortex effect, temperature stratification using the Leontief tube, expander-generator sets and devices based on the Hartmann-Sprenger effect. One of the most common devices at gas distribution stations (gas gate station) is the turboexpander. The principle of its operation is based on the expansion of the gas flow with the performance of external mechanical work. Taking into account the increased interest in hydrogen fuel in connection with the course announced by the UN for decarbonization of production by 2050, the modern gas transmission system can become a secondary source of electricity for hydrogen production, thereby solving the problem of excess pressure energy utilization at gas distribution stations. The technological solution for using this energy is the installation of turboexpanders and electrolysis of water at gate stations in order to produce hydrogen.
Zitieren
APA
Karimova, A., & Farukhshina, R. (2022). Use of gas reduction energy at a gas distribution station. Liquid and Gaseous Energy Resources. https://doi.org/10.21595/lger.2022.22421
Vancouver
Karimova A, Farukhshina R. Use of gas reduction energy at a gas distribution station. Liquid and Gaseous Energy Resources. 2022. doi:10.21595/lger.2022.22421
BibTeX
@article{Karimova2022,
author = {Karimova, Aigul and Farukhshina, Regina},
title = {Use of gas reduction energy at a gas distribution station},
journal = {Liquid and Gaseous Energy Resources},
year = {2022},
doi = {10.21595/lger.2022.22421}
}
EUVIMED